Pharming Group (PHAR) Stock
Pharming Group (PHAR) closed at $12.59 on Nov 16, 2026; its Tenet Score is 41 of 100 against 409 Healthcare peers.
Key stats
- Previous close
- $12.59
- Nov 16, 2026
- Market cap
- $883.4M
- share price × the latest quarter's diluted weighted-average share count (vendor)
- P/E
- 348.4×
- price ÷ the latest fiscal year EPS
- 52-week range
- 9.11 – 21.34
- low → high
- Tenet Score
- 41/100
- Weak · 409 Healthcare peers
Industry: Drugs · see every company filed here →
Pharming Group N.V. scores 41/100. Weak. Growth is the soft spot, trading at 348× earnings versus 409 Healthcare peers.
Tenet Score · vs sector
n=409Factor grades
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ~ Piotroski F-Score
- ~ Munger Compounders
- ✕ Magic Formula
- ✕ Graham Defensive
- ✕ Quality Compounder
Pharming Group N.V., a biopharmaceutical company, develops and commercialize protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally. The company's le…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 13, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Corvus Pharmaceuticals IncCRVS | 53 | $897.5M |
| MeiraGTx Holdings plcMGTX | 63 | $897.2M |
| 4D Molecular Therapeutics IncFDMT | 53 | $885.3M |
| Immatics N.VIMTX | 43 | $856.7M |
| Syndax Pharmaceuticals IncSNDX | 49 | $843.9M |
| Annexon IncANNX | 35 | $805.6M |
| Agility Robotics Inc.CCXI | 54 | $803.5M |
| Monte Rosa Therapeutics IncGLUE | 65 | $800.7M |
| Lexicon Pharmaceuticals IncLXRX | 51 | $797.0M |
| Collegium Pharmaceutical, IncCOLL | 61 | $786.8M |
Common questions
What sector and industry is Pharming Group in?
Pharming Group is in the Healthcare sector and the Drugs industry.
What is Pharming Group's Tenet Score?
Pharming Group's Tenet Score is 41 out of 100, ranked against 409 Healthcare peers as of Nov 16, 2026.




